Ousted BARDA Director Bright Says Hydroxychloroquine EUA Distracted From Coronavirus Work

 
• By Derrick Gingery

Rick Bright also tells House hearing that CDER Director Woodcock alerted him to the potential of the drug as a coronavirus treatment.

Rick Bright faces Commerce Health Subcommittee with his lawyer Debra Katz on 14 May 2020
Rick Bright faces the House Commerce Health Subcommittee with his lawyer Debra Katz on 14 May 2020. • Source: Screenshot of hearing broadcast

More from US FDA

More from Agency Leadership